# Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use

> **NCT03491371** · NA · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 56 (actual)

## Conditions studied

- Efficacy
- Toxicity

## Interventions

- **DRUG:** Methylsulfonic apatinib

## Key facts

- **NCT ID:** NCT03491371
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2017-02-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-04-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03491371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03491371, "Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03491371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*